GlassScriptPhysician profile
Paula Alem
NPI 1629508064
$654.39
in general payments reported to CMS, 2019-2025
8 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $78.54 · 2023: $28.43 · 2024: $400 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $350.28 | 2024-2025 | Restrata Wound Matrix |
| Polynovo North America LLC | $78.54 | 2022 | |
| Avita Medical Americas, LLC | $66.31 | 2023-2025 | Recell, Permeaderm, Cohealyx |
| Urgo Medical North America, LLC | $52.19 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Smith+Nephew, INC. | $40.63 | 2024-2025 | "Acticoat 4"" X 4""", Collagenase Santyl |
| Vericel Corporation | $31.79 | 2025 | Nexobrid |
| Convatec INC. | $18.91 | 2025 | |
| Amgen INC. | $15.74 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Alem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.